larotrectinib sulfate

Spain

Drugs containing this active substance

  • VITRAKVI 100 MG HARD CAPSULES

    It is used in adults, adolescents, and children to treat solid tumors (cancer) caused by a change in the NTRK gene, provided they are advanced, have spread, or surgery would involve serious complications, and no other satisfactory treatment options exist.

    Form: capsules, hard

    Active substance Dosage
    larotrectinib sulfate 122,9 mg

    ATC: L01E L01EX L01EX12

    Manufacturer: Bayer Ag

  • It is used in adults, adolescents, and children to treat solid tumors (cancer) caused by a genetic change in the neurotrophic tyrosine kinase receptor (NTRK) gene, when the cancer is advanced, has spread, surgery is complicated, and no other satisfactory treatment options are available.

    Form: solution, oral

    Active substance Dosage
    larotrectinib sulfate 24,6 mg/ml

    ATC: L01E L01EX L01EX12

    Manufacturer: Bayer Ag

  • It is used in adults, adolescents, and children to treat solid tumors (cancer) caused by a change in the NTRK gene, provided they are advanced, have spread, or surgery would involve serious complications and no other satisfactory treatment options are available.

    Form: capsules, hard

    Active substance Dosage
    larotrectinib sulfate 30,7 mg

    ATC: L01E L01EX L01EX12

    Manufacturer: Bayer Ag